Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh

*Corresponding author: Abdul Kader Mohiuddin, Alumni, Faculty of Pharmacy, Dhaka University, Bangladesh, Tel: +01935183385, ORCID: 0000-0003-1596-9757, Web of Science Researcher ID: T-5428-2019; E-mail: [email protected].

Received Date: December 01, 2022

Published Date: December 26, 2022

Citation: Mohiuddin AK. (2022). Prudent use of NSAIDs in patients with COVID-19, Dengue, and Chikungunya. Mathews J Pharma Sci. 6(1):13.

Copyrights: Mohiuddin AK. © (2022).

ABSTRACT

NSAIDs are most common pharmacological options for pain management, although their use is questionable in many viral diseases like COVID-19, Dengue, and Chikungunya. Newer studies suggest limiting their use in such cases and also reinforces more careful considerations in patients with liver and kidney injuries or concurrent administration with other drugs/nutraceuticals such as antioxidants or SSRIs.

Keywords: Pain Management, Cautions with SSRIs, Hypertensive Patients with Viral Fever, Misuse of NSAIDs, NSAIDs in Kidney or Liver-compromised Patients.